Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 306 million compared to USD 289 million a year ago. Revenue was USD 11,865 million compared to USD 11,337 million a year ago.

Net loss was USD 11,911 million compared to net income of USD 2,262 million a year ago. Basic loss per share from continuing operations was USD 5.89 compared to basic earnings per share from continuing operations of USD 1.08 a year ago. Diluted loss per share from continuing operations was USD 5.89 compared to diluted earnings per share from continuing operations of USD 1.07 a year ago.